KindlyMD (NAKA) Competitors $11.77 -0.32 (-2.65%) As of 07/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NAKA vs. VMD, TOI, DCGO, XGN, EUDA, SERA, QIPT, KDLY, ATPC, and CORBFShould you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include Viemed Healthcare (VMD), Oncology Institute (TOI), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Kindly MD (KDLY), Agape ATP (ATPC), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry. KindlyMD vs. Its Competitors Viemed Healthcare Oncology Institute DocGo Exagen EUDA Health Sera Prognostics Quipt Home Medical Kindly MD Agape ATP Global Cord Blood KindlyMD (NASDAQ:NAKA) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership. Does the media favor NAKA or VMD? In the previous week, KindlyMD had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Viemed Healthcare. KindlyMD's average media sentiment score of 0.94 beat Viemed Healthcare's score of 0.93 indicating that KindlyMD is being referred to more favorably in the media. Company Overall Sentiment KindlyMD Positive Viemed Healthcare Positive Which has preferable valuation and earnings, NAKA or VMD? Viemed Healthcare has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindlyMD$2.72M26.09-$3.62M-$0.77-15.29Viemed Healthcare$224.26M1.17$11.27M$0.3022.07 Is NAKA or VMD more profitable? Viemed Healthcare has a net margin of 5.28% compared to KindlyMD's net margin of -177.01%. Viemed Healthcare's return on equity of 9.49% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets KindlyMD-177.01% -146.26% -109.19% Viemed Healthcare 5.28%9.49%7.14% Which has more risk & volatility, NAKA or VMD? KindlyMD has a beta of 35.16, meaning that its stock price is 3,416% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Do insiders & institutionals believe in NAKA or VMD? 74.2% of Viemed Healthcare shares are owned by institutional investors. 50.5% of KindlyMD shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryViemed Healthcare beats KindlyMD on 8 of the 13 factors compared between the two stocks. Get KindlyMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAKA vs. The Competition Export to ExcelMetricKindlyMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.90M$7.25B$5.62B$9.29BDividend YieldN/A2.86%4.25%4.03%P/E Ratio-15.2934.4428.5719.58Price / Sales26.0934.57423.3293.40Price / CashN/A25.1136.0257.93Price / Book27.378.098.135.54Net Income-$3.62M$236.06M$3.24B$257.73M7 Day Performance-4.70%-3.35%0.16%-0.08%1 Month Performance-22.00%-0.38%5.95%8.09%1 Year PerformanceN/A19.35%26.09%13.02% KindlyMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAKAKindlyMDN/A$11.77-2.6%N/AN/A$72.90M$2.72M-15.29N/AVMDViemed Healthcare1.2363 of 5 stars$7.02+2.2%N/A-3.1%$271.53M$224.26M23.401,179TOIOncology Institute1.8624 of 5 stars$2.50-2.3%$7.00+180.0%+494.0%$228.44M$393.41M-3.57660DCGODocGo2.1887 of 5 stars$1.55+2.0%$3.56+129.7%-55.3%$155.01M$616.55M-77.504,407Positive NewsXGNExagen3.9026 of 5 stars$6.95-0.1%$7.50+7.9%+242.4%$148.25M$55.64M-8.27220News CoveragePositive NewsHigh Trading VolumeEUDAEUDA Health1.2558 of 5 stars$3.35+0.6%N/A-15.4%$123.73M$4.01M0.002Positive NewsSERASera Prognostics0.4017 of 5 stars$2.72+12.4%N/A-61.6%$91.17M$80K-2.89120High Trading VolumeQIPTQuipt Home Medical3.1569 of 5 stars$1.80+4.0%$2.85+58.3%-35.3%$75.16M$245.91M-8.571,200KDLYKindly MDN/A$12.04-5.6%N/A+414.5%$72.51M$2.47M-15.64N/AGap UpATPCAgape ATP0.548 of 5 stars$1.39-0.5%N/A-65.6%$69.76M$1.32M-2.3140CORBFGlobal Cord BloodN/A$0.55+0.1%N/AN/A$66.91M$196.12M0.001,200Gap Down Related Companies and Tools Related Companies Viemed Healthcare Alternatives Oncology Institute Alternatives DocGo Alternatives Exagen Alternatives EUDA Health Alternatives Sera Prognostics Alternatives Quipt Home Medical Alternatives Kindly MD Alternatives Agape ATP Alternatives Global Cord Blood Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAKA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAKA Stock Alerts